These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10386200)

  • 1. Documenting informed consent for antipsychotic medication.
    Holzapfel S
    Can Fam Physician; 1999 Jun; 45():1403-4, 1415-6. PubMed ID: 10386200
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In that case: Karen is a 31-year-old woman who suffers from schizophrenia and has been treated with an anti-psychotic medication for a number of years. Commentary.
    Cole S
    N Z Bioeth J; 2001 Jun; 2(2):32-3. PubMed ID: 15586998
    [No Abstract]   [Full Text] [Related]  

  • 4. Informed consent in medication-free schizophrenia research.
    Moser DJ; Reese RL; Schultz SK; Benjamin ML; Arndt S; Fleming FW; Andreasen NC
    Am J Psychiatry; 2005 Jun; 162(6):1209-11. PubMed ID: 15930073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consent to treatment.
    Jackson GA; McGrath A
    Br J Psychiatry; 1996 Sep; 169(3):382-3. PubMed ID: 8879733
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of schizophrenia with "uninformed" medication of antipsychotic drug in community--remodeling the concept of "protection" in informed consent].
    Kumakura N
    Seishin Shinkeigaku Zasshi; 1995; 97(2):106-16. PubMed ID: 7732151
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Karen.
    Smith M
    N Z Bioeth J; 2002 Jun; 3(2):27-8. PubMed ID: 15587496
    [No Abstract]   [Full Text] [Related]  

  • 8. Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.
    Brabbins C; Butler J; Bentall R
    Br J Psychiatry; 1996 May; 168(5):540-4. PubMed ID: 8733791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychology of competence and informed consent: understanding decision-making with regard to clinical practice.
    Rosenfeld B
    Fordham Urban Law J; 2002 Nov; 30(1):173-85. PubMed ID: 15868668
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: Willingness and competence of depressed and schizophrenic inpatients to consent to research.
    Appelbaum PS
    J Am Acad Psychiatry Law; 2004; 32(2):144-7. PubMed ID: 15282873
    [No Abstract]   [Full Text] [Related]  

  • 11. Informed consent for antipsychotic medication.
    Schachter D; Kleinman I; Williams JI
    Can Fam Physician; 1999 Jun; 45():1502-8. PubMed ID: 10386214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitute consent for nursing home residents prescribed psychotropic medication.
    Rendina N; Brodaty H; Draper B; Peisah C; Brugue E
    Int J Geriatr Psychiatry; 2009 Mar; 24(3):226-31. PubMed ID: 18666309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involving the resident/decision maker in antipsychotic medication use.
    Mort JR
    S D Med; 2013 Apr; 66(4):148-9. PubMed ID: 23697039
    [No Abstract]   [Full Text] [Related]  

  • 14. Capacity assessment and intervention in 56-yr-old man with schizophrenia.
    Schlechter A
    Mt Sinai J Med; 2008; 75(2):153-5. PubMed ID: 18500718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patients' perspective on the quality of informed consent into psychopharmacological treatment in schizophrenia and depression].
    Schildmann J; Bauer A; Tilmann A; Vollmann J
    Fortschr Neurol Psychiatr; 2003 May; 71(5):265-70. PubMed ID: 12740758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In that case: Karen is a 31-year-old woman who suffers from schizophrenia and has been treated with an anti-psychotic medication for a number years. Commentary.
    Romans S
    N Z Bioeth J; 2001 Jun; 2(2):34-5. PubMed ID: 15719457
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.
    Stroup TS; Appelbaum PS; Gu H; Hays S; Swartz MS; Keefe RS; Kim SY; Manschreck TC; Boshes RA; McEvoy JP; Lieberman JA
    Schizophr Res; 2011 Aug; 130(1-3):47-52. PubMed ID: 21561740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In that case: Karen is 31-year-old woman who suffers from schizophrenia and has been treated with an anti-psychotic medication for a number of years. Commentary.
    Kenny G
    N Z Bioeth J; 2001 Jun; 2(2):33-4. PubMed ID: 15719456
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
    Kleinman I; Schachter D; Jeffries J; Goldhamer P
    Hosp Community Psychiatry; 1993 Dec; 44(12):1189-91. PubMed ID: 7907571
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS dementia complex, competency to informed consent, risk assessment, and the ADC defense.
    Ragan MR
    AIDS Public Policy J; 1989; 4(4):183-92. PubMed ID: 11650316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.